ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 502 • 2016 ACR/ARHP Annual Meeting

    Use, Usability and Feasibility of a Mapp for Patients with Rheumatoid Arthritis – First Results

    Christina Kampling1, Gamal Chehab2, Hasan Acar1, Arnd Becker3, Matthias Schneider4 and Jutta G. Richter5, 1Policlinic of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 2Policlinic of Rheumatology, Heinrich-Heine-University, 40225 Duesseldorf, Germany, 3Ortenau Klinikum Offenburg-Gengenbach, Gengenbach, Gengenbach, Germany, 4Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 5Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

    Background/Purpose: Within the MiDEAR (Mobile medically supervised patient management in rheumatoid arthritis patients using DocuMed.rh and RheumaLive App) project patients (pts) with rheumatoid arthritis (RA)…
  • Abstract Number: 503 • 2016 ACR/ARHP Annual Meeting

    Anti-CCP Titer and Prevalence Is Influenced By Age at Rheumatoid Arthritis Onset- Analysis Based on a Nationwide Database in Japan

    Eri Kato1, Tetsuji Sawada1, Koichiro Tahara2, Haeru Hayashi2, Mayu Tago2, Hiroaki Mori2, Shigeru Yoshizawa3, Jinju Nishino4, Toshihiro Matsui5 and Shigeto Tohma6, 1Rheumatology, Tokyo Medical University, Shinjuku Tokyo, Japan, 2Rheumatology, Tokyo Medical University, Tokyo, Japan, 3Department of Rheumatology, Fukuoka Hospital, National Hospital Organization, Fukuoka, Japan, 4Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan, 5Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan, 6Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan

    Background/Purpose: Previous studies demonstrated the lower prevalence of anti-CCP antibody and rheumatoid factor (RF) in elderly-onset rheumatoid arthritis (EORA). However, anti-CCP antibody titer in EORA…
  • Abstract Number: 504 • 2016 ACR/ARHP Annual Meeting

    Clinical Significance of Multiple Autoantibody Specificities in Rheumatoid Arthritis: The Role of Anti-Citrullinated Alpha-Enolase and Anti-Interferon Inducible Protein 16 Antibodies

    Alessia Alunno1, Onelia Bistoni1, Federico Pratesi2, Valeria Caneparo3, Fabiana Topini1, Ilaria Puxeddu2, Marco De Andrea4, Santo Landolfo4, Paola Migliorini2 and Roberto Gerli1, 1Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 2Department of Clinical and Experimental Medicine, Clinical Immunology Unit, University of Pisa, Pisa, Italy, 3Department of Translational Medicine, Virology Unit, Novara Medical School, Novara, Italy, 4Department of Public Health and Pediatric Sciences, Viral Pathogenesis Unit, Turin Medical School, Torino, Italy

    Background/Purpose: Anti-cyclic citrullinated peptide (anti-CCP) auto-antibodies (auto-Abs) represent the current gold standard for the diagnosis of rheumatoid arthritis (RA). However, growing evidence suggests that a…
  • Abstract Number: 505 • 2016 ACR/ARHP Annual Meeting

    The Longitudinal Stability of the RA Biomarkers RF and ACPA in Classifying RA Subtypes over Extended Follow up

    Carl Orr, Francis Young and Douglas J. Veale, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland

    Background/Purpose: In recent years several studies suggest that first order stratification of RA should be based on the presence or absence of rheumatoid factor (RF)…
  • Abstract Number: 506 • 2016 ACR/ARHP Annual Meeting

    The Relationship Between Elevations in CRP with Physical Function and Radiographic Progression over the Long-Term in Patients with Rheumatoid Arthritis

    Arthur Kavanaugh1, Boulos Haraoui2, Prashanth Sunkureddi3, Benjamin Wolfe4, Li Wang4, Jessica Suboticki4 and Edward Keystone5, 1University of California San Diego, La Jolla, CA, 2University of Montreal, Montreal, QC, Canada, 3University of Texas Medical Branch, Galveston, TX, 4AbbVie Inc., North Chicago, IL, 5Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: For patients (pts) with rheumatoid arthritis (RA), quantification of radiographic progression, through measures such as modified total Sharp score (mTSS), is not routinely captured…
  • Abstract Number: 507 • 2016 ACR/ARHP Annual Meeting

    Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis

    Sonia Unriza-Puin1, Wilson Bautista-Molano2,3, Gloria Lafaurie4, Rafael R. Valle-Oñate5, Phillipe Chalem6, Lorena Chila3, Juan Manuel Bello7 and Consuelo Romero Sanchez3,8, 1Unit of Oral Basic Investigation, School of Dentistry, Universidad El Bosque, Bogota, Colombia, 2Rheumatology Department School of Medicine HMC / UMNG, Bogotá, Colombia, 3Unit of Oral Basic Investigation, School of Dentistry, Universidad El Bosque, Bogotá, Colombia, 4Unit of Oral Basic Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia, 5Rheumatology, Rheumatology Department School of Medicine HMC / UMNG, Bogota, Colombia, 6Fundación Instituto de Reumatología Fernando Chalem, Bogotá, Colombia, 7Rheumatology Department School of Medicine HMC / UMNG, Bogota, Colombia, 8Rheumatology, School of Medicine HMC / UMNG, Bogota, Colombia

    Background/Purpose:  Association studies in rheumatoid arthritis (RA) have been focused in the pre-clinical phases of the disease in asymptomatic individuals with higher risk to develop…
  • Abstract Number: 508 • 2016 ACR/ARHP Annual Meeting

    Before Clinically Detectable Arthritis Develops, ACPA-Positive and ACPA-Negative Arthralgia Patients Have Different Symptoms

    Leonie E Burgers1, Hanna W van Steenbergen1, Lukas Mangnus2, Tom WJ Huizinga1 and Annette HM van der Helm-van Mil1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose:  Anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) have different genetic risk factors and underlying biological mechanisms. Therefore, we hypothesized that patients’ characteristics…
  • Abstract Number: 509 • 2016 ACR/ARHP Annual Meeting

    Association of Anti-Citrullinated Protein Antibody Positivity and Titer Levels to Low Hand BMD, and the Consequence of Low Hand BMD on DAS28 (CRP) Remission in Established RA: Findings from a US Observational Cohort

    H Ahmad1, E Alemao1, Z Guo1, M Frits2, Michael Weinblatt2 and N A Shadick2, 1Bristol-Myers Squibb, Princeton, NJ, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Hand bone mineral density (BMD) loss is an independent predictor of radiographic joint progression,1 and a potential indicator of vertebral and non-vertebral fracture risk.2…
  • Abstract Number: 510 • 2016 ACR/ARHP Annual Meeting

    C-Reactive Protein and Disease Activity in Rheumatoid Arthritis: Impact of Obesity and Adiposity

    Michael D. George1, Jon T. Giles2, Patricia P. Katz3, Said Ibrahim4, Grant W. Cannon5, Bryant R. England6, Liron Caplan7, Brian Sauer8, Kaleb Michaud9, Ted R Mikuls10 and Joshua F. Baker1, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, Columbia University Medical Center, NY, NY, 3Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 4Medicine, University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA Medical Center and University of Utah Division of Rheumatology, Salt Lake City, UT, 6Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 7Denver Veterans Affairs Medical Center and UC Denver SOM, Denver, CO, 8IDEAS Center and Division of Epidemiology, HSR&D SLC VA Medical Center and University of Utah, Salt Lake City, UT, 9University of Nebraska Medical Center, Omaha, NE, 10Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: C-reactive protein (CRP) is used to assess disease activity in rheumatoid arthritis (RA), and previous work suggests that adiposity also impacts CRP levels. This…
  • Abstract Number: 511 • 2016 ACR/ARHP Annual Meeting

    Complement C3 and C4 Levels and Its Correlation with Disease Activity in Rheumatoid Arthritis Patients

    Julia Sosa1, Silvia Beatriz Papasidero2, María Alejandra Medina1, Diana Klajn3, Rafael Chaparro del Moral2, José Angel Caracciolo4, Luciana Casalla5, Lucía Zárate5, Nieves Capozzi5, Josefina Marcos6, Mercedes Argentina García6, Ana Quinteros7, Maria Olga Leal7, Dora Lia Vásquez7, María Inés Stancich8, Analia Alvarez9, Carolina Sanchez Andía9, Karin Kirmayr10, María de los Ángeles Correa11 and A. Constantino12, 1Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 2Rheumatology Department, Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 3Research Committee, Research Committee, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 4Rhematology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 5Rheumatology Section, Hospital Posadas, Buenos Aires, Argentina, 6Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 7Centro Integral De Reumatologia, Tucumán, Argentina, 8Rheumatology Department, Hospital Nacional De Clínicas, Córdoba, Argentina, 9Rheumatology Department, Hospital Penna, Buenos Aires, Argentina, 10Rheumatology Department, Sanatorio San Carlos, Buenos Aires, Argentina, 11Rheumatology Department, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 12Hospital Nacional De Clínicas, Córdoba, Argentina

    COMPLEMENT C3 AND C4 LEVELS AND ITS CORRELATION WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS   Background/Purpose: Cytokines play a major role in the pathogenesis…
  • Abstract Number: 512 • 2016 ACR/ARHP Annual Meeting

    Anti-Cyclic Citrullinated Protein Antibody (ACPA) Positivity in General Population and Follow-up Results for ACPA Positive Persons

    Yoichiro Haji1, Ryo Rokutanda2, Mitsumasa Kishimoto2 and Masato Okada2, 1Rheumatology, Daido Hospital, Nagoya, Japan, 2Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan

    Background/Purpose: To evaluate anti-cyclic citrullinated protein antibody positivity in the general population and to identify its prognosis. Methods: Anti-cyclic citrullinated protein antibody (ACPA) were measured…
  • Abstract Number: 513 • 2016 ACR/ARHP Annual Meeting

    Low Serum 25-Hydroxyvitamin D Level Is Not Associated with Decreased Bone Mass or Bone Quality in Patients with Rheumatoid Arthritis

    Kentaro Inui1, Tatsuya Koike2, Yuko Sugioka3, Tadashi Okano1, Kenji Mamoto4, Masahiro Tada5 and Hiroaki Nakamura4, 1Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Center for Senile Degenerative Disorders, Osaka City University Medical School, Osaka, Japan, 3Center for Senile Degenerative Disorders (CSDD), Osaka City University Medical School, Osaka, Japan, 4Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 5Orthopedic Surgery, Osaka City General Hospital, Osaka, Japan

    Background/Purpose:  Vitamin D deficiency in patients with rheumatoid arthritis (RA) is commonly observed. Previous studies have investigated the relationship between vitamin D deficiency and RA…
  • Abstract Number: 514 • 2016 ACR/ARHP Annual Meeting

    Gender Difference Is Apparent in the Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis

    Kentaro Inui1, Tatsuya Koike2, Tadashi Okano1, Kenji Mamoto3, Kazuki Orita1, Yuko Sugioka4, Masahiro Tada5, Hiroaki Nakamura3 and Orita incl, 1Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Center for Senile Degenerative Disorders, Osaka City University Medical School, Osaka, Japan, 3Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 4Center for Senile Degenerative Disorders (CSDD), Osaka City University Medical School, Osaka, Japan, 5Orthopedic Surgery, Osaka City General Hospital, Osaka, Japan

    Background/Purpose: Forefoot involvement in patients with rheumatoid arthritis (RA) is common, and reported to be present in 50–90% of patients without any clear gender predisposition.…
  • Abstract Number: 515 • 2016 ACR/ARHP Annual Meeting

    The Association of Body Mass Index with the Severity of  Magnetic Resonance Imaging-Detected Inflammation at Presentation; Opposite Effects in Early Rheumatoid Arthritis Compared to Other Arthritides and an Asymptomatic Population

    L. Mangnus1, W.P. Nieuwenhuis2, H.W. van Steenbergen2, T.W.J. Huizinga3, M. Reijnierse4 and A.H.M. van der Helm-van Mil2, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: An increased body mass index (BMI) has been associated with slightly increased inflammatory markers in the population. Within rheumatoid arthritis (RA) a high BMI…
  • Abstract Number: 516 • 2016 ACR/ARHP Annual Meeting

    Development of RA Patient Preference Phenotypes

    Liana Fraenkel1,2, Carole Wiedmeyer3, Gayathri Herath2, George Michel4 and Ben Nowell3, 1Medicine, Yale University School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT, 3CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, 4Yale University, New Haven, CT

    Background/Purpose: Many important treatment decisions for patients with RA are conditional on patient preferences and according to the Institute of Medicine mandate a shared decision…
  • « Previous Page
  • 1
  • …
  • 1631
  • 1632
  • 1633
  • 1634
  • 1635
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology